Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP400557.RAiyGrmpqG50T22ZwI9RL_Q26WT2XNL42B-JuS-avhjWg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP400557.RAiyGrmpqG50T22ZwI9RL_Q26WT2XNL42B-JuS-avhjWg130_assertion type Assertion NP400557.RAiyGrmpqG50T22ZwI9RL_Q26WT2XNL42B-JuS-avhjWg130_head.
- NP400557.RAiyGrmpqG50T22ZwI9RL_Q26WT2XNL42B-JuS-avhjWg130_assertion description "[These results suggest evidence of selective over-expression of FGFR1 and FGFR4 in clinical prostate cancer and support the notion of targeted inhibition of these receptors to disrupt FGF signalling.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP400557.RAiyGrmpqG50T22ZwI9RL_Q26WT2XNL42B-JuS-avhjWg130_provenance.
- NP400557.RAiyGrmpqG50T22ZwI9RL_Q26WT2XNL42B-JuS-avhjWg130_assertion evidence source_evidence_literature NP400557.RAiyGrmpqG50T22ZwI9RL_Q26WT2XNL42B-JuS-avhjWg130_provenance.
- NP400557.RAiyGrmpqG50T22ZwI9RL_Q26WT2XNL42B-JuS-avhjWg130_assertion SIO_000772 17607666 NP400557.RAiyGrmpqG50T22ZwI9RL_Q26WT2XNL42B-JuS-avhjWg130_provenance.
- NP400557.RAiyGrmpqG50T22ZwI9RL_Q26WT2XNL42B-JuS-avhjWg130_assertion wasDerivedFrom befree-20150227 NP400557.RAiyGrmpqG50T22ZwI9RL_Q26WT2XNL42B-JuS-avhjWg130_provenance.
- NP400557.RAiyGrmpqG50T22ZwI9RL_Q26WT2XNL42B-JuS-avhjWg130_assertion wasGeneratedBy ECO_0000203 NP400557.RAiyGrmpqG50T22ZwI9RL_Q26WT2XNL42B-JuS-avhjWg130_provenance.